What SEC filings does Ardent Health, Inc. submit to the SEC?

Ardent Health, Inc. (ARDT) submits several types of SEC filings including Form 4 (insider transactions), Form 144 (proposed insider sales), 8-K reports (material events such as earnings releases, acquisitions, leadership changes), and periodic reports — the 10-Q (quarterly) and 10-K (annual). All filings are publicly available through SEC EDGAR.

What does a Form 4 filing tell me about ARDT?

A Form 4 for ARDT discloses a transaction by a company insider — typically a director, officer, or 10%+ shareholder. It shows the source-reported date, number of shares, price, and updated ownership. These facts do not establish motive or predict future returns.

How do I interpret an 8-K filing from Ardent Health, Inc.?

An 8-K signals a material event requiring prompt disclosure. Common triggers include earnings pre-announcements, acquisitions, leadership appointments or departures, credit changes, or regulatory actions. Read the item codes inside the filing to understand exactly what was disclosed before drawing conclusions.

What is the difference between a 10-K and 10-Q for ARDT?

The 10-K is Ardent Health, Inc.'s annual report with fully audited financial statements, comprehensive MD&A, and complete risk factor disclosures — filed 60–90 days after fiscal year-end. The 10-Q is a lighter quarterly report with unaudited financials filed for the first three quarters. Together they provide a continuous financial picture of the company.

Where can I see all ARDT SEC filings directly on EDGAR?

You can view all historical Ardent Health, Inc. filings on the SEC EDGAR company page for ARDT. Each filing card on this page links directly to the original SEC document.

How often does Ardent Health, Inc. file with the SEC?

Ardent Health, Inc. files one 10-K per year and up to three 10-Qs per year. Form 4 insider transactions must be reported within two business days of each trade, so the frequency depends on how often insiders are buying or selling ARDT shares. 8-K filings occur whenever a material event happens — which can be several times per quarter for an active company.

ARDT SEC Filing News — Ardent Health, Inc.

Latest SEC filings for Ardent Health, Inc. (ARDT) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-09-29.

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, amb…

Sector: Healthcare Industry: Medical Care Facilities Market Cap: $1.6B CIK: 1756655

Total Filings

Bullish Classifications

Bearish Classifications

Insider Transactions

Material Events (8-K)

Periodic Reports

Rule-based classifications for ARDT currently lean bullish. Of the 20 displayed SEC filing records, 2 carry bullish classifications versus 0 bearish classifications. These labels summarize filing attributes; they are not recommendations, probabilities, or evidence of future price direction. There were 8 insider transactions (Form 4) in this period.

ARDT Filing Activity Snapshot 2026-04-02 — 2026-09-29

Insider Transactions (Form 4)

2 buys vs 0 sells

Net insider buying in this period — more purchases than sales reported.

Largest Form 144 Filing

$401.4K

Bonick Martin · 2026-08-25

35,930 shares · Form 144

Form 144 Notices

Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.

Insider Transactions 8 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 8 filings in this group are Form 4s for Ardent Health, Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 8 insider filings shown, the breakdown is 3 compensation award, 3 tax withholding and 2 open-market purchase. 2 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Compensation award ×3: Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Tax withholding ×3: Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.
Open-market purchase ×2: The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Form 4 Tax withholding Tax / Compensation Filing 2026-09-29

ARDT insider Form 4 filed for equity award, exercise, or tax withholding

LUMSDAINE ALFRED (Chief Financial Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`F`	Tax withholding on vested shares	3,389	$10.54	$35.7K

Filing: Form 4 (Insider Transaction) Insider: LUMSDAINE ALFRED (Chief Financial Officer) Shares: 3,389

View on SEC EDGAR → Open Filing Document →

Form 4 Tax withholding Tax / Compensation Filing 2026-09-29

ARDT insider Form 4 filed for equity award, exercise, or tax withholding

Petrovich Stephen C. (EVP, GC and Secretary) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`F`	Tax withholding on vested shares	788	$10.54	$8.3K

Filing: Form 4 (Insider Transaction) Insider: Petrovich Stephen C. (EVP, GC and Secretary) Shares: 788

View on SEC EDGAR → Open Filing Document →

Form 4 Tax withholding Tax / Compensation Filing 2026-09-29

ARDT insider Form 4 filed for equity award, exercise, or tax withholding

Byers David Raynor (SVP & Chief Accounting Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`F`	Tax withholding on vested shares	524	$10.54	$5.5K

Filing: Form 4 (Insider Transaction) Insider: Byers David Raynor (SVP & Chief Accounting Officer) Shares: 524

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-07-02

ARDT insider Form 4 filed for equity award, exercise, or tax withholding

Caspers Dave (Director, CEO and President) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award	103,653	—	—

Filing: Form 4 (Insider Transaction) Insider: Caspers Dave (Director, CEO and President) Shares: 103,653

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market purchase Insider Buying 2026-06-08

ARDT insider DeMichiei Robert (Director) bought 11,260 shares (~$98.3K)

DeMichiei Robert, listed as Director at Ardent Health, Inc., reported an open-market purchase of 11,260 ARDT shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`P`	Open-market purchase	11,260	$8.73	$98.3K

Filing: Form 4 (Insider Transaction) Insider: DeMichiei Robert (Director) Shares: 11,260 Est. Value: $98.3K

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market purchase Insider Buying 2026-06-08

ARDT insider LUMSDAINE ALFRED (Chief Financial Officer) bought 10,000 shares (~$88.1K)

LUMSDAINE ALFRED, listed as Chief Financial Officer at Ardent Health, Inc., reported an open-market purchase of 10,000 ARDT shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`P`	Open-market purchase	10,000	$8.81	$88.1K

Filing: Form 4 (Insider Transaction) Insider: LUMSDAINE ALFRED (Chief Financial Officer) Shares: 10,000 Est. Value: $88.1K

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-04-02

ARDT insider Form 4 filed for equity award, exercise, or tax withholding

Bulgarelli Peter J. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award	14,231	—	—

Filing: Form 4 (Insider Transaction) Insider: Bulgarelli Peter J. (Director) Shares: 14,231

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-04-02

ARDT insider Form 4 filed for equity award, exercise, or tax withholding

Havdala Ellen (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award	14,231	—	—

Filing: Form 4 (Insider Transaction) Insider: Havdala Ellen (Director) Shares: 14,231

View on SEC EDGAR → Open Filing Document →

Proposed Insider Sales 4 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Ardent Health, Inc. has 4 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-08-27

ARDT Form 144 filed for proposed insider sale by Bonick Martin (35,930 shares) ~$398.0K

Bonick Martin filed a Form 144 with the SEC indicating intent to sell ARDT (Ardent Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Bonick Martin Shares: 35,930 Est. Value: $398.0K

View on SEC EDGAR → Open Filing Document →

Form 144 Proposed Insider Sale 2026-08-25

ARDT Form 144 filed for proposed insider sale by Bonick Martin (35,930 shares) ~$401.4K

Filing: Form 144 (Proposed Sale Notice) Insider: Bonick Martin Shares: 35,930 Est. Value: $401.4K

View on SEC EDGAR → Open Filing Document →

Form 144 Proposed Insider Sale 2026-08-20

ARDT Form 144 filed for proposed insider sale by Bonick Martin (35,930 shares) ~$377.4K

Filing: Form 144 (Proposed Sale Notice) Insider: Bonick Martin Shares: 35,930 Est. Value: $377.4K

View on SEC EDGAR → Open Filing Document →

Form 144 Proposed Insider Sale 2026-08-18

ARDT Form 144 filed for proposed insider sale by Bonick Martin (35,930 shares) ~$393.5K

Filing: Form 144 (Proposed Sale Notice) Insider: Bonick Martin Shares: 35,930 Est. Value: $393.5K

View on SEC EDGAR → Open Filing Document →

Material Events 6 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 6 in this period for Ardent Health, Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-09-04